Literature DB >> 27381391

The Role of Signaling via Aqueous Pore Formation in Resistance Responses to Amphotericin B.

B Eleazar Cohen1.   

Abstract

Drug resistance studies have played an important role in the validation of antibiotic targets. In the case of the polyene antibiotic amphotericin B (AmB), such studies have demonstrated the essential role that depletion of ergosterol plays in the development of AmB-resistant (AmB-R) organisms. However, AmB-R strains also occur in fungi and parasitic protozoa that maintain a normal level of ergosterol at the plasma membrane. Here, I review evidence that shows not only that there is increased protection against the deleterious consequences of AmB-induced ion leakage across the membrane in these resistant pathogens but also that a set of events are activated that block the cell signaling responses that trigger the oxidative damage produced by the antibiotic. Such signaling events appear to be the consequence of a membrane-thinning effect that is exerted upon lipid-anchored Ras proteins by the aqueous pores formed by AmB. A similar membrane disturbance effect may also explain the activity of AmB on mammalian cells containing Toll-like receptors. These resistance mechanisms expand our current understanding of the role that the formation of AmB aqueous pores plays in triggering signal transduction responses in both pathogens and host immune cells.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27381391      PMCID: PMC4997855          DOI: 10.1128/AAC.00878-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  94 in total

Review 1.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

2.  MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine.

Authors:  A van Helvoort; A J Smith; H Sprong; I Fritzsche; A H Schinkel; P Borst; G van Meer
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

3.  Structure, composition, and peptide binding properties of detergent soluble bilayers and detergent resistant rafts.

Authors:  M Gandhavadi; D Allende; A Vidal; S A Simon; T J McIntosh
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

4.  In vitro and in vivo role of heat shock protein 90 in Amphotericin B resistance of Aspergillus terreus.

Authors:  G Blum; B Kainzner; K Grif; H Dietrich; B Zeiger; T Sonnweber; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2012-04-19       Impact factor: 8.067

5.  C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells.

Authors:  Brandon C Wilcock; Matthew M Endo; Brice E Uno; Martin D Burke
Journal:  J Am Chem Soc       Date:  2013-06-03       Impact factor: 15.419

6.  Gene expression and evolution of antifungal drug resistance.

Authors:  James B Anderson; Caroline Sirjusingh; Nazia Syed; Shantelle Lafayette
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

7.  Amphotericin B channels in the bacterial membrane: role of sterol and temperature.

Authors:  Berenice Venegas; Javier González-Damián; Heliodoro Celis; Iván Ortega-Blake
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

8.  Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants.

Authors:  Michael Blatzer; Emina Jukic; Wilfried Posch; Bernd Schöpf; Ulrike Binder; Marion Steger; Gerhard Blum; Hubert Hackl; Erich Gnaiger; Cornelia Lass-Flörl; Doris Wilflingseder
Journal:  Antioxid Redox Signal       Date:  2015-10-08       Impact factor: 8.401

9.  Effect of amphotericin B on cholesterol-containing liposomes of egg phosphatidylcholine and didocosenoyl phosphatidylcholine. A refinement of the model for the formation of pores by amphotericin B in membranes.

Authors:  P van Hoogevest; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1978-08-17

10.  Plasma Membrane Proteolipid 3 Protein Modulates Amphotericin B Resistance through Sphingolipid Biosynthetic Pathway.

Authors:  Vinay K Bari; Sushma Sharma; Md Alfatah; Alok K Mondal; K Ganesan
Journal:  Sci Rep       Date:  2015-05-12       Impact factor: 4.379

View more
  12 in total

1.  Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response.

Authors:  Edubiel A Alpizar-Sosa; Nur Raihana Binti Ithnin; Wenbin Wei; Andrew W Pountain; Stefan K Weidt; Anne M Donachie; Ryan Ritchie; Emily A Dickie; Richard J S Burchmore; Paul W Denny; Michael P Barrett
Journal:  PLoS Negl Trop Dis       Date:  2022-09-28

Review 2.  Leishmaniasis in humans: drug or vaccine therapy?

Authors:  Masoud Ghorbani; Ramin Farhoudi
Journal:  Drug Des Devel Ther       Date:  2017-12-22       Impact factor: 4.162

3.  Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicans.

Authors:  Helene Tournu; Jennifer Carroll; Brian Latimer; Ana-Maria Dragoi; Samantha Dykes; James Cardelli; Tracy L Peters; Karen E Eberle; Glen E Palmer
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

4.  Increasing the Fungicidal Action of Amphotericin B by Inhibiting the Nitric Oxide-Dependent Tolerance Pathway.

Authors:  Kim Vriens; Phalguni Tewari Kumar; Caroline Struyfs; Tanne L Cools; Pieter Spincemaille; Tadej Kokalj; Belém Sampaio-Marques; Paula Ludovico; Jeroen Lammertyn; Bruno P A Cammue; Karin Thevissen
Journal:  Oxid Med Cell Longev       Date:  2017-10-10       Impact factor: 6.543

5.  Pore-forming activity of new conjugate antibiotics based on amphotericin B.

Authors:  Svetlana S Efimova; Anna N Tevyashova; Evgenia N Olsufyeva; Evgeny E Bykov; Olga S Ostroumova
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

6.  Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis.

Authors:  Gert-Jan Wijnant; Katrien Van Bocxlaer; Vanessa Yardley; Andy Harris; Mo Alavijeh; Rita Silva-Pedrosa; Sandra Antunes; Isabel Mauricio; Sudaxshina Murdan; Simon L Croft
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-04-12       Impact factor: 4.077

7.  Topical Amphotericin B Semisolid Dosage Form for Cutaneous Leishmaniasis: Physicochemical Characterization, Ex Vivo Skin Permeation and Biological Activity.

Authors:  Diana Berenguer; Mª Magdalena Alcover; Marcella Sessa; Lyda Halbaut; Carme Guillén; Antoni Boix-Montañés; Roser Fisa; Ana Cristina Calpena-Campmany; Cristina Riera; Lilian Sosa
Journal:  Pharmaceutics       Date:  2020-02-12       Impact factor: 6.321

8.  Spatial and Temporal Variability of Visceral Leishmaniasis in Colombia, 2007 to 2018.

Authors:  Adriana Castillo-Castañeda; Giovanny Herrera; Martha S Ayala; Patricia Fuya; Juan David Ramírez
Journal:  Am J Trop Med Hyg       Date:  2021-07-07       Impact factor: 3.707

Review 9.  Ras signalling in pathogenic yeasts.

Authors:  Daniel R Pentland; Elliot Piper-Brown; Fritz A Mühlschlegel; Campbell W Gourlay
Journal:  Microb Cell       Date:  2017-12-18

Review 10.  Membrane Thickness as a Key Factor Contributing to the Activation of Osmosensors and Essential Ras Signaling Pathways.

Authors:  B Eleazar Cohen
Journal:  Front Cell Dev Biol       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.